Header

UZH-Logo

Maintenance Infos

Trypsin and Chymotrypsin [MAK Value Documentation, 2016]


van Kampen, V; Hartwig, A; MAK Commission; et al; Arand, Michael (2017). Trypsin and Chymotrypsin [MAK Value Documentation, 2016]. The MAK Collection for Occupational Health and Safety, 2(3):1170-1176.

Abstract

Trypsin (EC 3.4.21.4) and Chymotrypsin (EC 3.4.21.1) are proteolytic pancreatic enzymes which are secreted as inactive precursors trypsinogen and chymotrypsinogen, respectively. They have several clinical pharmacological as well as laboratory applications and they are used in protein chemistry, especially in the preparation of insulin. Exposure to enzyme dusts has long been known to cause occupational immediate hypersensitivities of the airways. Also trypsin and chymotrypsin are potential inhalable sensitizers; cases of specific airway sensitization caused by trypsin and chymotrypsin containing products could be shown clearly by several studies. Positive skin prick and challenge tests as well as specific IgE antibodies have been described. Since these results and the clinical symptoms usually matched well, an immunological mechanism of action is suggested. There is no clear evidence of allergic cell‐mediated late type eczematous skin reactions. Trypsin and chymotrypsin are designated with “Sa” (for substances causing airway sensitization) but not with “Sh” (for skin‐sensitizing substances).

Abstract

Trypsin (EC 3.4.21.4) and Chymotrypsin (EC 3.4.21.1) are proteolytic pancreatic enzymes which are secreted as inactive precursors trypsinogen and chymotrypsinogen, respectively. They have several clinical pharmacological as well as laboratory applications and they are used in protein chemistry, especially in the preparation of insulin. Exposure to enzyme dusts has long been known to cause occupational immediate hypersensitivities of the airways. Also trypsin and chymotrypsin are potential inhalable sensitizers; cases of specific airway sensitization caused by trypsin and chymotrypsin containing products could be shown clearly by several studies. Positive skin prick and challenge tests as well as specific IgE antibodies have been described. Since these results and the clinical symptoms usually matched well, an immunological mechanism of action is suggested. There is no clear evidence of allergic cell‐mediated late type eczematous skin reactions. Trypsin and chymotrypsin are designated with “Sa” (for substances causing airway sensitization) but not with “Sh” (for skin‐sensitizing substances).

Statistics

Citations

Dimensions.ai Metrics

Altmetrics

Additional indexing

Item Type:Journal Article, not_refereed, original work
Communities & Collections:04 Faculty of Medicine > Institute of Pharmacology and Toxicology
07 Faculty of Science > Institute of Pharmacology and Toxicology
Dewey Decimal Classification:570 Life sciences; biology
610 Medicine & health
Language:English
Date:26 July 2017
Deposited On:17 Oct 2019 12:36
Last Modified:17 Oct 2019 12:38
Publisher:Wiley-VCH Verlag
ISSN:2509-2383
ISBN:9783527600410
OA Status:Closed
Publisher DOI:https://doi.org/10.1002/3527600418.mb900207e6017

Download

Full text not available from this repository.
View at publisher

Get full-text in a library